Pfizer
PFE
PFE
1,964 hedge funds and large institutions have $134B invested in Pfizer in 2016 Q1 according to their latest regulatory filings, with 113 funds opening new positions, 920 increasing their positions, 729 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less call options, than puts
Call options by funds: $3.49B | Put options by funds: $3.78B
8% less capital invested
Capital invested by funds: $146B → $134B (-$11.5B)
21% less funds holding in top 10
Funds holding in top 10: 253 → 201 (-52)
Holders
1,964
Holding in Top 10
201
Calls
$3.49B
Puts
$3.78B
Top Buyers
| 1 | +$1.62B | |
| 2 | +$1.24B | |
| 3 | +$720M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$717M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$300M |
Top Sellers
| 1 | -$701M | |
| 2 | -$471M | |
| 3 | -$282M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$251M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
-$244M |